Rchr
J-GLOBAL ID:201401070651989333   Update date: Sep. 17, 2022

Okabe Takafumi

Okabe Takafumi
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/70460863.ja.html
Research field  (1): Tumor diagnostics and therapeutics
MISC (23):
more...
Lectures and oral presentations  (18):
  • 進行肺腺癌」を対象としたゲフィチニブ/S-1併用療法第I相臨床試験
    (第50回日本肺癌学会総会 2009)
  • Matuzumab and cetuximab activateb the epidermal growth factor receptor but fail to trigger downstream signaling by akt or erk
    (A.A.C.R 2008)
  • ヒト肺癌細胞株におけるS-1とゲフィチニブの併用効果の検討
    (第48回日本肺癌学会総会 2007)
  • Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling
    (66th Annual Meeting of the Japanese Cancer Association 2007)
  • Synergistic effects of S-1 and gefitinib by modulating the metabolic enzymes of 5-fluorouracil in NSCLC cell lines
    (2007)
more...
Work history (1):
  • 2011 - Kindai University Faculty of Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page